Wireless Brain Sensors Market

Executive Summary

Wireless Brain Sensors Market was valued at US $358.97 million in 2021 and is projected to grow at 8.81% CAGR over the forecast period to reach US $595.87 million by 2027. Wireless Brain Sensors Market represented US $55.79 million opportunity over 2019-2021 and estimated to create US $236.90 million opportunity in 2027 over 2021.

Wireless Brain Sensors from Consainsights analyses the Wireless Brain Sensors Market in the Life Sciences industry over the forecast period to 2027.

Wireless Brain Sensors research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Wireless Brain Sensors segmentation includes Product Type, Application and Geography.

Based on the Product Type, the Wireless Brain Sensors analysis covers Devices, Accessories.

In Product Type segment, Devices segment has highest cagr growth of 7.80%.

Based on the Application, the Wireless Brain Sensors analysis covers Traumatic Brain Injuries, Dementia, Sleep Disorders, Others.

In Application segment, Traumatic Brain Injuries segment has highest cagr growth of 7.80%.

Based on the region, the Wireless Brain Sensors analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include NeuroSky, EMOTIV, Advanced Brain Monitoring, Inc., Koninklijke Philips N.V., Medtronic Plc, InteraXon Inc., Natus Medical Incorporated, Cadwell Industries, Inc., NeuroWave Systems Inc., BrainScope and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product Type

Introduction

In 2021, Devices segment has the highest revenue of US $273.93 million and is expected to grow at CAGR of 7.80% by 2027 Devices segment has highest cagr growth of 7.80%.

Devices

Devices segment was valued at US $231.35 million in 2019 and is projected to grow at 7.80% CAGR over the forecast period to reach US $454.70 million by 2027. Devices segment represented US $42.58 million opportunity over 2019-2021 and estimated to create US $180.77 million opportunity in 2027 over 2021.

Accessories

Accessories segment was valued at US $71.83 million in 2019 and is projected to grow at 7.80% CAGR over the forecast period to reach US $141.17 million by 2027. Accessories segment represented US $13.22 million opportunity over 2019-2021 and estimated to create US $56.12 million opportunity in 2027 over 2021.

Application

Introduction

In 2021, Traumatic Brain Injuries segment has the highest revenue of US $157.20 million and is expected to grow at CAGR of 7.80% by 2027 Traumatic Brain Injuries segment has highest cagr growth of 7.80%.

Traumatic Brain Injuries

Traumatic Brain Injuries segment was valued at US $132.76 million in 2019 and is projected to grow at 7.80% CAGR over the forecast period to reach US $260.93 million by 2027. Traumatic Brain Injuries segment represented US $24.43 million opportunity over 2019-2021 and estimated to create US $103.74 million opportunity in 2027 over 2021.

Dementia

Dementia segment was valued at US $85.56 million in 2019 and is projected to grow at 7.80% CAGR over the forecast period to reach US $168.16 million by 2027. Dementia segment represented US $15.75 million opportunity over 2019-2021 and estimated to create US $66.86 million opportunity in 2027 over 2021.

Sleep Disorders

Sleep Disorders segment was valued at US $67.10 million in 2019 and is projected to grow at 7.80% CAGR over the forecast period to reach US $131.88 million by 2027. Sleep Disorders segment represented US $12.35 million opportunity over 2019-2021 and estimated to create US $52.43 million opportunity in 2027 over 2021.

Others

Others segment was valued at US $17.75 million in 2019 and is projected to grow at 7.80% CAGR over the forecast period to reach US $34.89 million by 2027. Others segment represented US $3.27 million opportunity over 2019-2021 and estimated to create US $13.87 million opportunity in 2027 over 2021.